Re-expression of estrogen receptor β inhibits the proliferation and migration of ovarian clear cell adenocarcinoma cells

Oncology Reports

Volumn 26, Issue 6, 2011, Pages 1497-1503

  Zhu, Jing ^a   Hua, Keqin ^a   Sun, Hong ^a   Yu, Yinhua ^a   Jin, Hongyan ^a   Feng, Youji ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Estrogen receptor ; Invasion; Ovarian clear cell adenocarcinoma; Proliferation; Stable transfection

Indexed keywords

CYCLIN D1; ESTROGEN RECEPTOR BETA; GELATINASE A; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA;

ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL CYCLE PROGRESSION; CELL MOTILITY; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MIGRATION INHIBITION; MITOSIS INHIBITION; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; WESTERN BLOTTING;

ADENOCARCINOMA, CLEAR CELL; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D1; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION; HUMANS; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; RECOMBINANT PROTEINS;

EID: 80053495859     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1430     Document Type: Article

References (33)

1. Chan JK, Teoh D, Hu JM, Shin JY, Osann K and Kapp DS: Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol 109: 370-376, 2008.
2. Behbakh K, Randall T, Benjamin I, Morgan MA, King S and Rubin SC: Clinical characteristics of clear cell carcinoma of the ovary. Gynecol Oncol 70: 255-258, 1998. (Pubitemid 28430939)
3. Pectasides D, Pectasides E, Psyrri A and Economopoulos T: Treatment issues in clear cell carcinoma of the ovary: a different entity? Oncologist 11: 1089-1094, 2006. (Pubitemid 44788400)
4. Komiyama S, Aoki D, Katsuki Y and Nozawa S: Proliferative activity of early ovarian clear cell adenocarcinoma depends on association with endometriosis. Eur J Obstet Gynecol Reprod Biol 127: 130-136, 2006. (Pubitemid 43947435)
5. Komiyama S, Aoki D, Tominaga E, Susumu N, Udagawa Y and Nosawa S: Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation. Gynecol Oncol 72: 342-346, 1999. (Pubitemid 29118191)
6. Nezhat F, Datta MS, Hanson V, Pejovic T, Nezhat C and Nezhat C: The relationship of endometriosis and ovarian malignancy: a review. Fertil Steril 90: 1559-1570, 2008.
7. Akahane T, Sekizawa A, Okuda T, Kushima M, Saito H and Okai T: Disappearance of steroid hormone dependency during malignant transformation of ovarian clear cell cancer. Int J Gynecol Pathol 24: 369-376, 2005. (Pubitemid 41368291)
8. Syed V, Ulinski G, Mok SC, Yiu GK and Ho SM: Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. Cancer Res 61: 6768-6776, 2001. (Pubitemid 32896499)
9. Syed V, Ulinski G, Mok C and Ho SM: Reproductive hormone induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells. J Natl Cancer Inst 94: 617-629, 2002. (Pubitemid 34498649)
10. Cunat S, Hoffmann P and Pujol P: Estrogens and epithelial ovarian cancer. Gynecol Oncol 94: 25-32, 2004. (Pubitemid 38950494)
11. Mosselman S, Polman J and Dijkema R: ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett 392: 49-53, 1996. (Pubitemid 26268330)
12. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S and Gustafsson JÅ: Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93: 5925-5930, 1996. (Pubitemid 26190778)
13. Pace P, Taylor J, Suntharalingam S, Coombes RC and Ali S: Human estrogen receptor β binds DNA in a manner similar to and dimerizes with estrogen receptor β. J Biol Chem 272: 25832-25838, 1997. (Pubitemid 27438906)
14. Rutherford T, Brown WD, Sapi E, Aschkenazi S, Muñoz A and Mor G: Absence of estrogen receptor-β; expression in metastatic ovarian cancer. Obstet Gynecol 96: 417-421, 2000.
15. Bardin A, Hoffmann P, Boulle N, Katsaros D, Vignon F, Pujol P and Lazennec G: Involvement of estrogen receptor β in ovarian carcinogenesis. Cancer Res 64: 5861-5869, 2004. (Pubitemid 39095587)
16. Lindgren PR, Cajander S, Bäckström T, Gustafsson JA, Mäkelä S and Olofsson JI: Estrogen and progesterone receptors in ovarian epithelial tumors. Mol Cell Endocrinol 221: 97-104, 2004. (Pubitemid 38829727)
17. Pujol P, Rey JM, Nirde P, Roger P, Gastaldi M, Laffargue G, Rochefort F and Maudelonde T: Differential expression of estrogen receptor-β and -β messenger RNAs as a potential marker of ovarian carcinogenesis. Cancer Res 58: 5367-5373, 1998. (Pubitemid 28551118)
18. Roger P, Sahla ME, Mäkelä S, Gustafsson JA, Baldet P and Rochefort H: Decreased expression of receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 61: 2537-2541, 2001. (Pubitemid 32685835)
19. Skliris GP, Munot K, Bell SM, et al: Reduced expression of oestrogen receptor beta in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model. J Pathol 201: 213-220, 2003. (Pubitemid 37258932)
20. Fixemer T, Remberger K and Bonkhoff H: Differential expression of the estrogen receptor beta in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma. Prostate 54: 79-87, 2003. (Pubitemid 36120323)
21. Horvath LG, Henshall SM, Lee CS, et al: Frequent loss of estrogen receptor-beta expression in prostate cancer. Cancer Res 61: 5331-5335, 2001. (Pubitemid 32694904)
22. Campbell-Thompson M, Lynch J and Bhardwaj B: Expression of estrogen receptor (ER) subtypes ER beta isoforms in colon cancer. Cancer Res 61: 632-640, 2001. (Pubitemid 32128626)
23. Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O and Rice LW: Selective loss of estrogen receptor beta in malignant human colon. Cancer Res 60: 245-248, 2000. (Pubitemid 30070743)
24. Gougelet A, Mueller SO, Korach KS and Renoir JM: Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)β-mediated transcriptional repression of ERá. J Steroid Biochem 104: 110-122, 2007. (Pubitemid 46901024)
25. Behrens D, Gill JH and Fichtner I: Loss of tumourigenicity of stably ERβ-transfected MCF-7 breast cancer cells. Mol Cell Endocrinol 274: 19-29, 2007. (Pubitemid 47161102)
26. Lazennec G, Bresson D, Lucas A, Chauveau C and Vignon F: ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology 9: 4120-4130, 2001. (Pubitemid 32802685)
27. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL and Leitman DC: Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 64: 423-428, 2004. (Pubitemid 38114127)
28. Liu MM, Albanese C, Anderson CM, et al: Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J Biol Chem 277: 24353-24360, 2002. (Pubitemid 34951956)
29. Omoto y, Inoue S, Ogawa S, et al: Clinical value of the wild-type estrogen receptor beta expression in breast cancer. Cancer Lett 163: 207-212, 2001.
30. Ström A, Hartman J, Foster JS, Kietz S, Wimalasena J and Gustafsson JA: Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA 101: 1566-1571, 2004. (Pubitemid 38236167)
31. Pravettoni A, Mornati O, Martini PGV, Marino M, Colciago A, Celotti F, Motta M and Negri-Cesi P: Estrogen receptor beta (ERbeta) and inhibition of prostate cancer cell proliferation: studies on the possible mechanism of action in DU145 cells. Mol Cell Endocrinol 263: 46-54, 2007. (Pubitemid 44828230)
32. Cheng J, Lee EJ, Madison LD and Lazennec G: Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis. FEBS Lett 566: 169-172, 2004. (Pubitemid 38625953)
33. Driggers PH, Segars JH and Rubino DM: The proto-oncoprotein Brx activates estrogen receptor beta by a p38 mitogen-activated protein kinase pathway. J Biol Chem 276: 46792-46797, 2001.